ATRECA INC has a total of 36 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and chemical engineering are BIOO SCIENT CORP, CEMU BIOTEKNIK AB and DYNAL AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Singapore | 3 | |
#5 | Australia | 2 | |
#6 | Canada | 2 | |
#7 | China | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Chemical engineering | |
#4 | Measurement | |
#5 | Organic fine chemistry | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Withey Gary | 19 |
#2 | Tan Yann Chong | 16 |
#3 | Lippow Shaun M | 11 |
#4 | Volkmuth Wayne | 9 |
#5 | Serafini Tito | 7 |
#6 | Defalco Jeff | 7 |
#7 | Kim Dongkyoon | 6 |
#8 | Lewis George K | 6 |
#9 | Devico Anthony | 6 |
#10 | Cavet Guy L | 6 |
Publication | Filing date | Title |
---|---|---|
WO2020172220A1 | Anti-csp antibody variants | |
US2020325242A1 | Antibodies that bind tumor tissue for diagnosis and therapy | |
WO2019173802A1 | Anti-hiv antibodies | |
WO2019173801A1 | Nucleic acids encoding anti-hiv antibodies | |
WO2019173794A1 | Anti-hiv antibodies | |
EP3621643A1 | Anti-malarial antibodies that bind circumsporozoite protein | |
KR20180097536A | A combination set of nucleic acid barcodes for the analysis of nucleic acids associated with single cells | |
CN106460033A | Analysis of nucleic acids associated with single cells using nucleic acid barcodes | |
US2015011405A1 | Use of Nanoexpression to Interrogate Antigen Repertoires | |
WO2013033721A1 | Dna barcodes for multiplexed sequencing |